Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | C188 - Critical Care Consultations for Neurohospitalists

Thursday 04/27/23
07:00 AM - 09:00 AM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Jana Wold, MD
Neuro Trauma and Critical Care
Participants should be able to employ methods to recognize patients at risk for delirium and enact treatments for in-hospital delirium; recognize the neurologic side effects of emerging cancer therapies and how to mitigate the risk of such side effects; and discuss updates to the prognostication of neurologic outcomes in cardiac arrest patients.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Intermediate
Fellow, Resident, General Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
07:05 AM - 07:40 AM EST Speaker The Dark Side of Emerging Cancer Therapies
Alexandra Muccilli, MD
07:40 AM - 08:15 AM EST Speaker Delirium Management for the Neurohospitalist
Sara LaHue, MD
08:15 AM - 08:50 AM EST Speaker Updates in Prognostication and Management of Anoxic Brain Injury
Jana Wold, MD
Faculty Disclosures
Jana Wold, MD Dr. Wold has nothing to disclose.
Sara LaHue, MD The institution of Dr. LaHue has received research support from National Institute on Aging . The institution of Dr. LaHue has received research support from Larry L. Hillblom Foundation . The institution of Dr. LaHue has received research support from UCSF Claude D. Pepper Older Americans Independence Center . The institution of Dr. LaHue has received research support from UCSF Bakar Aging Research Institute. Dr. LaHue has received publishing royalties from a publication relating to health care.
Alexandra Muccilli, MD Dr. Muccilli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Muccilli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Muccilli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Muccilli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.